Reactive urticaria and severe thrombocytosis in a child with SARS-CoV-2 infection

Loading...
Thumbnail Image

Authors

Van Bruwaene, Lore
Green, Robin J.
Joshi, Jayneel A.
Cloete, Jeane

Journal Title

Journal ISSN

Volume Title

Publisher

Allergy Society of South Africa

Abstract

Coronavirus SARS-CoV-2 has made a significant impact around the world through COVID-19 and its related complications. Individuals with comorbid conditions and the elderly have been at risk of significant inflammatory complications, including the cytokine release syndrome (CRS) and acute respiratory distress syndrome (ARDS). Children, on the other hand, have been less affected and have had less severe disease. However, reports from Europe and North America have described clusters of children and adolescents with paediatric multisystem inflammatory syndrome. Both adults and children have also exhibited a number of unusual disease manifestations. We present the case of a South African child, infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presenting with reactive urticaria and thrombocytosis, further broadening the clinical spectrum of COVID-19 in children.

Description

Keywords

Children, Urticaria, Thrombocytosis, COVID-19 pandemic, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Acute respiratory distress syndrome (ARDS), Cytokine release syndrome (CRS)

Sustainable Development Goals

Citation

Van Bruwaene, L., Green, R.J., Joshi, J.A. et al. 2020, 'Reactive urticaria and severe thrombocytosis in a child with SARS-CoV-2 infection', Current Allergy and Clinical Immunology, vol. 33, no. 3/4, pp. 154-156.